121 related articles for article (PubMed ID: 11431583)
1. Prolactin levels in Behçet's disease: no correlation with disease manifestations and activity.
Houman H; Ben Ghorbel I; Lamloum M; Feki M; Khanfir M; Mebazaa A; Miled M
Ann Med Interne (Paris); 2001 Apr; 152(3):209-11. PubMed ID: 11431583
[TBL] [Abstract][Full Text] [Related]
2. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
3. Serum prolactin levels in Behçet's Syndrome.
Keser G; Oksel F; Ozgen G; Aksu K; Doganavsargil E
Clin Rheumatol; 1999; 18(4):351-2. PubMed ID: 10468181
[TBL] [Abstract][Full Text] [Related]
4. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemia in males with systemic lupus erythematosus.
Mok CC; Lau CS; Lee KW; Wong RW
J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
[TBL] [Abstract][Full Text] [Related]
7. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
8. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
9. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
10. [Vena cava thrombosis in Behçet's disease. Analysis of a series of 10 cases].
Houman H; Lamloum M; Ben Ghorbel I; Khiari-Ben Salah I; Miled M
Ann Med Interne (Paris); 1999 Dec; 150(8):587-90. PubMed ID: 10686638
[TBL] [Abstract][Full Text] [Related]
11. Plasma thrombomodulin levels in patients with Behçet's disease.
Düzgün N; Ayaşlioğlu E; Tutkak H; Sahin M; Aydintuğ O; Olmez U
Rheumatol Int; 2003 May; 23(3):130-3. PubMed ID: 12739044
[TBL] [Abstract][Full Text] [Related]
12. Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients.
Tsai J; Chen GS; Lu YW; Wu CS; Lan CC
J Eur Acad Dermatol Venereol; 2008 May; 22(5):596-600. PubMed ID: 18266686
[TBL] [Abstract][Full Text] [Related]
13. The relation between serum homocysteine level and eye involvement in Behçet's disease.
Aflaki E; Mehryar M; Nazarinia MA; Habibagahi Z; Rajaee A; Ranjbar-Omrani G
Arch Iran Med; 2008 Nov; 11(6):625-8. PubMed ID: 18976033
[TBL] [Abstract][Full Text] [Related]
14. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
[TBL] [Abstract][Full Text] [Related]
15. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
[TBL] [Abstract][Full Text] [Related]
16. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
Buskila D; Lorber M; Neumann L; Flusser D; Shoenfeld Y
J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
18. Serum prolactin levels in Behçet's disease.
Apaydin KC; Duranoglu Y; Ozgürel Y; Saka O
Jpn J Ophthalmol; 2000; 44(4):442-5. PubMed ID: 10974304
[TBL] [Abstract][Full Text] [Related]
19. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement.
Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550
[TBL] [Abstract][Full Text] [Related]
20. Study of the correlation of serum selenium level with Behcet's disease.
Esalatmanesh K; Jamshidi A; Shahram F; Davatchi F; Masoud SA; Soleimani Z; Salesi M; Ghaffarpasand I
Int J Rheum Dis; 2011 Oct; 14(4):375-8. PubMed ID: 22004235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
